Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06319014 · ClinicalTrials.gov registry record · NA
Physical Activity to Mitigate PreEclampsia Risk
A NA study of Preeclampsia, sponsored by East Carolina University.
- Recruiting
- Registry status
- NA
- Development phase
- 224
- Enrollment target
- 1
- Study location
NCT06319014: Recruiting NA study of Preeclampsia, sponsored by East Carolina University.
NCT06319014 is a NA study of Preeclampsia that is actively recruiting participants, run by East Carolina University. The registered enrollment target is 224 participants, below the 1,122-participant average among 48 other Preeclampsia trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06319014, a NA study of Preeclampsia, is actively recruiting participants, sponsored by East Carolina University.
- RECRUITING
- Registry status
- NA
- Development phase
- 224 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effects of aerobic (AE), resistance (RE), and combination (AERE) exercise throughout pregnancy on selected maternal and fetal/neonatal physiological variables in women at-risk for preeclampsia. The central hypothesis of this project is that exercise will decrease severity and occurrence of preeclampsia symptoms, thus improving maternal, pregnancy, and birth outcomes. Aim 1. Determine the influence of different exercise modes during pregnancy at risk of preeclampsia on maternal cardiometabolic health. Aim 2. Determine the most effective exercise mode in pregnancy at risk of preeclampsia on improving birth and infant health outcomes.
Primary Outcome
resting SBP
Conditions Studied
Interventions
- BEHAVIORAL Exercise Modes
Study Locations (1)
North Carolina
- East Carolina University - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2024-06-24 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
What NCT06319014 shows while recruiting
NCT06319014 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 1,122-participant average among 48 other Preeclampsia trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Preeclampsia appearing as the primary indexed condition, and to 1 intervention - of which Exercise Modes is the first listed.
NCT06319014 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06319014 about?
NCT06319014 is a clinical study titled "Physical Activity to Mitigate PreEclampsia Risk". The purpose of this study is to compare the effects of aerobic (AE), resistance (RE), and combination (AERE) exercise throughout pregnancy on selected maternal and fetal/neonatal physiological variables in women at-risk for preeclampsia. The central hypothesis of this project is that exercise will d...
What is the current status of trial NCT06319014?
This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2024-06-24. Estimated completion is 2026-10-01.
What conditions does trial NCT06319014 study?
This clinical trial studies the following conditions: Preeclampsia.
What interventions are being tested in trial NCT06319014?
The interventions under investigation include: Exercise Modes (BEHAVIORAL).
Who is sponsoring clinical trial NCT06319014?
This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06319014 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06319014's enrollment target sits among peer trials
224 18th of 48 higher than 30 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
Preventing Obstetric Complications With Dietary Intervention
RECRUITING · NA
-
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
RECRUITING · NA
-
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
- NCT04915183 · 224 participants · Phase 2
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- NCT05519878 · 224 participants · NA
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI